ARCHIVES

Executive Branch Should Improve Science Pay, NAS Says

This article is from The Cancer Letter archive.

Vol. 19 No. 29 | July 16, 1993

Download PDF Visit The Full Archive

Related Articles

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Minority CCOP Applications Not Yet Reviewed

December 15, 1989